Safety and efficacy of glecaprevir and pibrentasvir in north Tohoku Japanese patients with genotype 1/2 hepatitis C virus infection

BACKGROUND AND AIMS: To assess the efficacy and safety of treatment with glecaprevir/pibrentasvir in Japanese patients with genotype (GT) 1/2 hepatitis C virus (HCV) infection in a real‐world clinical setting. METHODS: A total of 230 patients from 12 centers in northern Tohoku Japan with chronic hep...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyasaka, Akio, Yoshida, Yuichi, Murakami, Akihiko, Hoshino, Takao, Sawara, Kei, Numao, Hiroshi, Takikawa, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733835/
https://www.ncbi.nlm.nih.gov/pubmed/35024454
http://dx.doi.org/10.1002/hsr2.458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733835/
https://www.ncbi.nlm.nih.gov/pubmed/35024454
http://dx.doi.org/10.1002/hsr2.458

Ejemplares similares